Loading...

Dual‐Specificity Phosphatase 9 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through ASK1 Suppression

Nonalcoholic fatty liver disease (NAFLD), ranging from nonalcoholic fatty liver to nonalcoholic steatohepatitis (NASH), is the leading cause of chronic liver diseases. Until now, no medications for NAFLD have been approved by relevant governmental agencies. Dual‐specificity phosphatase 9 (Dusp9) is...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Hepatology
Main Authors: Ye, Ping, Xiang, Mei, Liao, Hua, Liu, Jijun, Luo, Hongbo, Wang, Yayun, Huang, Ling, Chen, Manhua, Xia, Jiahong
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6590435/
https://ncbi.nlm.nih.gov/pubmed/30063256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.30198
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!